ATM and Other metabolic disease: Indeed, dampening ATM accumulation and consequent inflammation, via monocyte chemoattractant CCL2/CCR2 pharmacological inhibition, Tamura et al. [50] showed an improvement of obesity and related metabolic disorders, such as insulin resistance and hepatic steatosis in db/db mice.